COCRYSTAL PHARMA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- COCRYSTAL PHARMA, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2018-09-30 was 0.00 shares.
- COCRYSTAL PHARMA, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2018-06-30 was 256.00K shares.
- COCRYSTAL PHARMA, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2018-03-31 was -128.00K shares.
- COCRYSTAL PHARMA, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2015 was -183.00 shares.
- COCRYSTAL PHARMA, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2014 was -1.09K shares.
- COCRYSTAL PHARMA, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2013 was -49.32K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | |
| 2018-06-30 | 256.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | |
| 2018-03-31 | -128.00K shares 10-Q · filed 2018-05-10 | |
| 2015-12-31 | -183.00 shares 10-K · filed 2016-03-15 | |
| 2014-12-31 | -1.09K shares 10-K · filed 2016-03-15 | |
| 2013-12-31 | -49.32K shares 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |